Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Dr Arezina article published in GMP review

16
August 2018

Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review ‘ The application of GMP and its role in maximising the

View Articles

Richmond Pharmacology Confirm event with the Department of International Trade

8
August 2018

View Articles

Officially an ILS Resuscitation Council Course Centre

7
March 2018

View Articles

Dr Jorg Taubel attending ACCP in San Diego

5
September 2017

View Articles

DIA, Chicago 2017

23
June 2017

View Articles

Richmond Pharmacology’s New London Bridge unit offers unrivalled access to patient recruitment

28
April 2017

Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.

View Articles

Latest news

Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director

August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read more

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Events

JSCPT 2025

5th –6th December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event